3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
5
Fallopian Tube Neoplasms
4
Peritoneal Neoplasms
3
Hyperthermia
3
Carcinoma, Ovarian Epithelial
3
Recurrence
1
Mesothelioma
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma
1
Brenner Tumor
1
Appendiceal Neoplasms
1
Adrenocortical Carcinoma
1
Abdominal Neoplasms
1
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
Cytoreduction Surgical Procedures
×
Clear all
No trials found.